Market Forecast News: Endoscopic Submucosal Dissection Industry to Hit $0.75B by 2030
The report "Endoscopic Submucosal Dissection Market by Product (Gastroscopes & Endoscopes, Injection Agent, Tissue Retractor), Indication (Stomach Cancer, Colon Cancer), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Center)- Global Forecast to 2030", is projected to reach USD 0.75 billion by 2030 from USD 0.50 billion in 2025, at a CAGR of 8.4% during the forecast period.
Browse through 197 market data tables and 57 figures spread across 234 pages and the in-depth TOC on the "Endoscopic Submucosal Dissection Market – Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/endoscopic-submucosal-dissection-market-116451960.html
The clinical indications for endoscopic submucosal dissection (ESD) have significantly broadened beyond its initial application in early gastric cancer, particularly in Japan. Today, ESD is increasingly used to treat colorectal lesions, esophageal cancers, and neoplasia associated with Barrett’s esophagus. This expansion of indications is driven by growing clinical confidence, improved tools, and an accumulation of evidence supporting the safety and efficacy of ESD across various gastrointestinal sites. As a result, ESD is gaining popularity in multiple GI subspecialties, leading to an increase in procedural volumes worldwide. This expansion is expected to be a major driver of market growth, bolstered by enhanced training and evolving clinical guidelines.
The gastroscopes & endoscopes segment held the largest share of the endoscopic submucosal dissection market in 2024.
The endoscopic submucosal dissection (ESD) market is categorized based on product types into gastroscopes & endoscopes, knives, injection agents, tissue retractors, grasp/clips, and other products. In 2024, the gastroscopes & endoscopes segment held the largest share of the global ESD market. The integration of AI-based detection and classification algorithms into endoscope platforms enhances the real-time identification of submucosal lesions, which increases the value of gastroscopes in ESD procedures and drives demand for this segment.
The stomach cancer segment held the largest share of the endoscopic submucosal dissection market in 2024.
The ESD market has been categorized into three segments based on indication: stomach cancer, colon cancer, and esophageal cancer. In 2024, stomach cancer accounted for the largest share of the ESD market. This is because the stomach offers a relatively wide and accessible area for ESD procedures, with fewer anatomical constraints than the esophagus or colon. As a result, the success and safety of procedures are higher, which contributes to the growth of the market.
In 2024, the Asia Pacific accounted for the largest share of the endoscopic submucosal dissection market.
In 2024, the Asia Pacific region held the largest share of the endoscopic submucosal dissection (ESD) market. This growth can be attributed to the rapid expansion of ambulatory surgical centers (ASCs), which prefer disposable instruments for their efficiency and speed, thus increasing demand. Additionally, numerous international fellowships and training centers in the Asia Pacific, particularly in Japan and South Korea, are producing a significant number of highly skilled ESD practitioners, which further drives the adoption of these procedures.
Key Market Players
The key players in the endoscopic submucosal dissection market include Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), Medtronic (Ireland), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group Plc (UK), HOYA Corporation (Japan), ConMed Corporation (US), STERIS (Ireland), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE & Co. KG (Germany), and Cook Medical (US), among others. These companies have implemented various growth strategies, including product launches, acquisitions, and expansions, to enhance their market presence and reach in the endoscopic submucosal dissection sector.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Endoscopic Submucosal Dissection/ESD Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
